Recent Updates
Recently added Catalysts

CASI Pharmaceuticals, Inc.

CASIFDA catalysts, PDUFA dates & pipeline intelligence
$0.21
▼ -0.13 · -38.97%

Last traded Feb 25, 2026. This price is not current.

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full CASI financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $0.2152W HIGH $3.09
Volume
9.96 M
Value Traded
3.01 M
Short % Float
1.78%
Days to Cover
4.2
-75.31%Week
-78.39%1 Month
-81.72%3 Month
-91.53%6 Month
-99.18%5 Year
-99.99%All Time

Cash Data

Unlock CASI cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
3.21 M
EPS (TTM)
-3.16
P/E Ratio
-
Ent. Value
17.38 M
Total Shares
20.55 M
Float Shares
5.10 M
Insiders
87.27%
Institutions
32.60%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
Unlock every CASI catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

CASI Catalyst Timeline

Dated clinical, regulatory and corporate events for CASI Pharmaceuticals, Inc.

Unlock the full CASI catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How CASI actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
No matching catalysts
Unlock all CASI historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

Pipeline Score
Pipeline Value
Valuation Signal
1
Drugs Scored
rNPV / MCap
Top Drug
Showing 3 of 26 assets
DrugIndicationPhasePTRSrNPVStatusEnrollVelocityDesignEst. CompletionML SignalLast Change
CID-103 Small moleculeNCT07017725Chronic Immune ThrombocytopeniaPhase 1/2 RECRUITING 75Dec 30, 2026
CID-103 Small moleculeNCT07641426Antibody Mediated RejectionPhase 1/2 RECRUITING 58Dec 1, 2030
CID-103 Small moleculeCompletedNCT04758767Multiple MyelomaPhase 1 COMPLETED 10Jan 19, 2023
Unlock the CASI pipeline intelligence model
PTRS, rNPV, enrollment velocity, trial design quality and ML risk signals for every asset above.
Institutional-grade data · Cancel anytime

Clinical Trial Results

Readouts, endpoints and source filings for every CASI program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
CID-103 chronic immune thrombocytopeniaPhase 12026-01-13primary efficacy endpoint achievement: 80%; complete response: 66%; patients evaluable: 15; patients with cr: 10; grade 3 treatment related events: 2Read MoreCASI Pharmaceuticals Announces Update and Additional Results from Phase 1 Study of CID-103 in Adult Patients with Chronic Immune ThrombocytopeniaRead More
Scroll for more · summaries link to the source press release
Unlock every CASI trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock CASI insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
SPECTRUM PHARMACEUTICALS INC10% OwnerBuyOffering 907,356 6,897,413 held$0.01 12/22/2017
Unlock the full CASI insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Hedge Funds invested in CASI

Fund % of Portfolio Current MV Shares Owned Activity
VR Adviser, LLC 0 % (-100 %) 839.17 K 987.26 K
Unlock every fund holding CASI
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in CASI
Shares held by hedge funds each quarter, and who bought or sold.

Ownership Trends

Sign in to see CASI ownership
Insider and institutional ownership, quarter by quarter.

CASI Short Interest

Shares sold short, counted twice a month.

1.78%
Short % of Float
of tradable shares sold short
90.9K
Shares Sold Short
-9.2% vs prior count
4.2 Moderate
Days to Cover
trading days of normal volume to buy every short share back
21.5K
Avg Daily Volume
the average used for days to cover
Unlock CASI short interest history
Two years of days to cover and shares sold short, with every count and its change.
Institutional-grade data · Cancel anytime

Options Data

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
Unlock CASI option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live CASI option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock CASI options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How CASI ranks across every disease it competes in

Competitive Position is a premium feature
See how CASI ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

CASI News

About CASI Pharmaceuticals, Inc.

Founded1991
BIOPHARMAWATCH ELITE PLUS
Trade the next CASI catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime